Author： Fra MD Gian Paolo Avanzi MD Gian Carlo
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.11, 2006-11, pp. : 1557-1568
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The Use of Hormonal Growth Factors in the Treatment of Patients with Short-Bowel Syndrome
Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. :
Azacitidine beneficial in myelodysplastic syndrome
Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. :
Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-01 ,pp. :